KGS · Investment summary · as of 4 August 2026
Priced slightly ahead of what the business has demonstrated
Business type: Compounder · cyclical or commodity-sensitive
The business does not meet the quality standard for its economic type.
At $58.06, KGS requires a 12% five-year revenue growth rate to justify its enterprise value — more than the business has ever demonstrated, at 4%.
The growth-axis margin (-8.5pp) is the less negative of the two axes and is where the disagreement with the market actually sits: the market underwrites a 12.5% revenue path against 4.0% demonstrated.
The conditions that would settle the disagreement are dated 3 years.
The value rests on an exit multiple of 15.6x, a terminal operating margin of 27% and a 8.4% cost of capital. Move any one of them materially and the conclusion moves with it, which is why the required-versus-demonstrated test above carries more weight here than the point value.
The strongest argument against this view: Named cause: a dividend defended through a Permian gas downcycle on a 3.89x-levered balance sheet, cut only after the balance sheet has absorbed the damage.
| Question | Evidence-based conclusion |
|---|---|
| What drives the business? | The growth-axis margin (-8.5pp) is the less negative of the two axes and is where the disagreement with the market actually sits: the market underwrites a 12.5% revenue path against 4.0% demonstrated. |
| What do we forecast? | Revenue growth of 4% demonstrated; a terminal operating margin of 27%; an exit multiple of 15.6x. |
| What does Street forecast? | Not determined — no consensus estimates are joined to this record |
| Where do we differ? | On revenue growth, the difference between what the price requires and what the business has demonstrated is -8.5 percentage points. |
| What is it worth? | Twelve-month target $43.54, -25% from the struck price. Scenario-weighted expected return net of costs -25.0%. |
| Why now? | Date not announced — no dated event that would resolve the disagreement is on file |
Date not announced — no dated event that would resolve the disagreement is on file
Named cause: a dividend defended through a Permian gas downcycle on a 3.89x-levered balance sheet, cut only after the balance sheet has absorbed the damage. The declared quarterly dividend of $0.49/share is a $194.7m annual run-rate on 99,334,407 shares against TTM free cash flow of $200.3m - a 97.2% payout of FCF BEFORE any of the growth capital management has publicly committed to ('funding growth capital for additional power generation equipment', 424B5 use of proceeds). Q1 2026 free cash flow was already -$47.2m as capex stepped to $118.4m. In a downturn the 9.0% of revenue-generating horsepower on 30-90 day notice leaves first, the 2027 RPO roll ($594.8m, 33.9% of that year's revenue) renews lower or not at all, and the shortfall is funded on the ABL - which is exactly what the ABL was used for in Q1-Q2 2026, when borrowings reached $967.8m before the equity offering paid them down.
Estimated probability 20%, against the 25% level at which the position would be resized. It sits within that level.
Falsifiable and fundamental — not one of them is a price condition.
Forward E[R] at the 12-month target is -25.0%, already below the E[R] > 0 floor, so on valuation and opportunity cost this is trim-or-exit at any size. On approach to the $43.54 target the case is reviewed rather than added to; a target reached is a reason to re-examine the position, not to hold it by default. The position is trimmed once forward expected return falls below 0% net of costs, because the capital has a better use elsewhere in the book.
| Criteria | Status | Investment meaning |
|---|---|---|
| Quality | Not met | Is the business worth owning under its declared economic type? |
| Valuation | Not met | Is the operating path required by today's price achievable? |
| Liquidity | Met | Can the intended position be built and exited in the right vehicle? |
| Downside | Met | Named cause: a dividend defended through a Permian gas downcycle on a 3.89x-levered balance sheet, cut only after the balance sheet has absorbed the damage. |
| Momentum | Not determined | Does price action support or complicate entry timing? Not established on the evidence on file. |
| Catalyst | Not determined | Is there a dated event that resolves the disagreement? Not established on the evidence on file. |
| Consensus | Not determined | Is the house-versus-Street disagreement identified and quantified? Not established on the evidence on file. |
Quality, valuation and liquidity can prevent a position on their own. The remaining four inform timing, sizing and monitoring, and never reject an investment by themselves.
The gap between what today's price requires and what the business has demonstrated is -8.5 percentage points, and that gap — not the multiple — is the case that the security is mispriced. The most important unresolved uncertainty is the permanent-loss mechanism: named cause: a dividend defended through a Permian gas downcycle on a 3.89x-levered balance sheet, cut only after the balance sheet has absorbed the damage. The next evidence that should change the portfolio decision is the next scheduled results, or a daily close below $48.49, which forces an immediate review.